Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2016-10-12
Original SEC Filing: Click here

---

Webplus: BSPM/20161012/8-K/2_EX-4.1/000.htm SEC Original: ex4-1.htm
BIOSTAR PHARMACEUTICALS, INC. Issuance Date Date of Issuance: October [•], 2016 (“ Company Holder 1 16 Securities Purchase Agreement Biostar Pharmaceuticals, Inc., a Maryland corporation (the “ 1. Mechanics of Exercise 1 (f) Exercise Notice Aggregate Exercise Price 1 (d) st Transfer Agent rd DTC (a) 1 This date is six months and a day after the closing. 1 (a)

---

---

Webplus: BSPM/20161012/8-K/3_EX-5.1/000.htm SEC Original: ex5-1.htm
October 12, 2016 Board of Directors Biostar Pharmaceuticals, Inc. No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 Re: Registration Statement on Form S-3 Company Shares Shares Shares Securities Purchase Agreement Registration Statement Commission Act Base Prospectus Prospectus Supplement Prospectus You have requested our opinion with respect to certain matters in connection with the offering by

---

---

Webplus: BSPM/20161012/8-K/4_EX-10.1/000.htm SEC Original: ex10-1.htm
SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers This RECITALS Registration Statement 1933 Act SEC Common Shares Common Stock B. Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms stated in this Agreement, (i) the aggregate number of shares of Common Stock (as defined below) set forth opposite such Buyer’s name in column

---

---

Webplus: BSPM/20161012/8-K/5_EX-99.1/000.htm SEC Original: ex99-1.htm
Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by the Company, are expected to be approximately $1.91 million. The net proceeds from this offering will be used for working capital and other general corporate purposes. The completion of the offering is expected to occur on or before October 17, 2016, subject to

---

---

Webplus: BSPM/20161012/8-K/1/000.htm SEC Original: biostarpharma8k101116.htm
FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): October 11 , 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐

---

Company Info:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2016-10-12CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046